Back to Results
First PageMeta Content
Chemistry / Pharmacology / Microbicides / Tenofovir / Bristol-Myers Squibb / Organofluorides / Entecavir / Hepatitis B / Reverse-transcriptase inhibitor / Purines / Gilead Sciences / Medicine


N21-356s042 Clinical PREA
Add to Reading List

Open Document

File Size: 2,45 MB

Share Result on Facebook

City

Reference / /

Company

Chemistry Manufacturing / Gilead Sciences / Reverse Transcriptase Gilead Sciences Inc. / Alteon Inc. / /

Country

United States / /

Event

FDA Phase / /

Facility

Laboratory Findings / /

IndustryTerm

treatment of HIV / /

MedicalCondition

lactic acidosis / injury / HBV / infection / hepatocellular carcinoma / chronic / liver disease / cirrhosis / Chronic Hepatitis B / hepatitis B / /

MedicalTreatment

vaccination / /

Organization

MD NDA / PDUFA Goal Date Division / /

Person

Prabha Viswanathan / Review Prabha Viswanathan / /

Position

Major / /

Product

Tenofovir Disoproxil Fumarate / Hepsera / Oral tablet / lamivudine / Viread / Epivir / adenosine / mannitol / Tyzeka / Intron A / Baraclude / Telbivudine Tyzeka® / Trade Name Dose ® Intron A Interferon / Viread® (Tenofovir ) / /

Technology

Pharmacokinetics / Pharmacodynamics / /

SocialTag